Mepolizumab Uses, Side Effects & Warnings - Drugs.com
WEBOct 10, 2023 · Mepolizumab is used to help prevent flare-ups or reduce symptoms of high eosinophil levels (hypereosinophilic syndrome, or HES) in adults and children at least 12 years old. Mepolizumab is also used in adults to help control symptoms and reduce flares of a rare autoimmune disorder called eosinophilic granulomatosis with polyangiitis (EPGA).
Mepolizumab - Wikipedia
WEBMepolizumab, sold under the brand name Nucala by GlaxoSmithKline, is a humanized monoclonal antibody used for the treatment of severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome (HES). [5]
Mepolizumab Injection: Uses & Side Effects - Cleveland Clinic
WEBMepolizumab is a medication that treats severe asthma. This condition causes your airways to narrow and swell. Mepolizumab can also treat condition that cause a high eosinophil count, which are a type of white blood cell.
Nucala Injection: Uses, Dosage & Side Effects - Drugs.com
WEBApr 1, 2024 · Nucala (mepolizumab) is used to treat severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, and chronic rhinosinusitis with nasal polyps. Includes Nucala side effects, interactions and indications.
Severe Asthma Treatment | NUCALA (mepolizumab)
WEBNUCALA is an add-on, prescription maintenance treatment for patients 6 and older with severe eosinophilic asthma. NUCALA is not used to treat sudden breathing problems. Learn about taking NUCALA at home.
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
WEBSep 25, 2014 · Patients were assigned to receive mepolizumab, a humanized monoclonal antibody against interleukin-5, which was administered as either a 75-mg intravenous dose or a 100-mg subcutaneous dose,...
Mepolizumab (Subcutaneous Route) Description and Brand Names - Mayo Clinic
WEBMar 1, 2024 · Mepolizumab injection is used with other medicines to treat severe asthma. It is given to patients whose asthma is not controlled with their current asthma medicines. It is also used to treat eosinophilic granulomatosis with polyangiitis (EGPA) and hypereosinophilic syndrome (HES).
FDA Approves First Drug to Treat Group of Rare Blood Disorders in ...
WEBSep 25, 2020 · Today FDA approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome (HES) for six months or longer without another identifiable non-blood ...
Mepolizumab Injection: MedlinePlus Drug Information
WEBMepolizumab injection is used along with other medications to prevent wheezing, difficulty breathing, chest tightness, and coughing caused by asthma in certain children 6 years of age and older and adults whose asthma is not controlled with …
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary …
WEBOct 26, 2017 · Mepolizumab, a humanized monoclonal antibody, reduces eosinophil counts in blood and tissues by blocking interleukin-5, a key eosinophil cytokine, through binding to eosinophil surface receptors...
Skip to content